COMMUNIQUÉS West-GlobeNewswire

Veru Announces the Sale of the FC2 Female Condom® (Internal Condom) Business
31/12/2024
MIAMI, FL, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, [...]
Vireo Growth Inc. Announces Closing of Oversubscribed US$81 Million Equity Securities Offering
31/12/2024
– Oversubscribed equity raise at US$0.625 per share capitalizes Company with a strong balance sheet– – Financing enables Vireo to fund investments in additional organic and acquisitive growth opportunities – MINNEAPOLIS [...]
Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study with Oral PB2 inhibitor CC-42344
31/12/2024
Data support favorable safety and tolerability profile with no serious adverse events (SAEs) or study-related drug discontinuations Enrollment to be extended due to low influenza infection among challenged participants [...]
Spectral AI Provides Instructions for Retail Investors on Exercising Publicly-Traded Warrants
31/12/2024
DALLAS, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”) , developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. FDA in [...]
Making Cancer Drugs Safer: CellMosaic CEO to Host Live Investment Webinar
31/12/2024
DoD-recognized biotech company opens investment round as its cancer treatment technology gains traction with 159+ global organizations. Woburn, MA, Dec. 31, 2024 (GLOBE NEWSWIRE) -- CellMosaic CEO Dr. Yumei Huang will [...]
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31/12/2024
CLEVELAND, , Dec. 31, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved [...]
Oncotelic Therapeutics Implements PDAOAI Platform
31/12/2024
AGOURA HILLS, Calif., Dec. 31, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), today announced the implementation of its artificial intelligence (AI) [...]
Galera Therapeutics completes acquisition of Nova Pharmaceuticals
31/12/2024
Galera’s development strategy shifts from toxicity reduction to anti-cancer therapeutics, with three trials in patients with highly resistant subsets of advanced breast cancer. Lead program is Phase 1/2 trial of Nova [...]
Burning Rock Announces Results of 2024 Annual General Meeting
31/12/2024
GUANGZHOU, China, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “ Company ” or “ Burning Rock ”), a company focusing on the application of next generation sequencing (NGS) technology [...]
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
31/12/2024
Communiqué de Presse Information relative au nombre total de droits de vote et d’actions composant le capital social Dijon, le 30 décembre 2024 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
31/12/2024
Déclaration de transactions sur actions propres Paris, France (31 décembre 2024, 8h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que du 24 décembre 2024 [...]
Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering
30/12/2024
Wuxi, China, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) (the “Company”), a company focused on developing private skincare labels, direct skincare product sales, and franchise [...]
ARCPOINT REACHES AGREEMENT TO SELL 68% OWNERSHIP STAKE IN NON-CORE ASSET
30/12/2024
Greenville, South Carolina, Dec. 30, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) reports that it has entered into an agreement for the sale (the “Transaction”) of its 68% share [...]
FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing
30/12/2024
HOUSTON, Dec. 30, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of [...]
ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
30/12/2024
PRINCETON, N.J., Dec. 30, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer; Stephen Carey, Chief [...]
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million
30/12/2024
WEST LAFAYETTE, Ind., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”) , a leading contract research organization specializing in nonclinical and analytical drug discovery and development [...]
NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports
30/12/2024
MELBOURNE, Australia and BRUSSELS, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) and the Brussels-based Oncidium foundation today announce that results for [...]
Award-winning band, Arkells, lend impactful song “Strong” to Alberta Cancer Foundation’s latest campaign
30/12/2024
EDMONTON, Alberta, Dec. 30, 2024 (GLOBE NEWSWIRE) -- The Alberta Cancer Foundation has teamed up with 9X JUNO Award winning band, Arkells, to spread the message of hope to Albertans facing cancer. Arkells’ poignant song [...]
IBA - Information réglementée
30/12/2024
Publication effectuée en vertu de l’article 15 de la loi du 2 mai 2007 relative à la publicité des participations importantes dans des émetteurs dont les actions sont admises à la négociation sur un marché réglementé et [...]

Pages